Latest Health News

Tag: roumeliotis

  • Bayer’s Monsanto acquisition to face politically charged scrutiny

    —

    by

    elegant
    in

    By Diane Bartz and Greg Roumeliotis WASHINGTON D.C./NEW YORK (Reuters) – As the global agricultural sector races to consolidate, Bayer AG's $66 billion all-cash deal to acquire Monsanto Co will test growing political and consumer unease in the United States and abroad over the future of food production. Bayer’s pesticide-focused agricultural business has few overlaps…

  • Bayer’s Monsanto acquisition to face politically charged scrutiny

    —

    by

    elegant
    in

    By Diane Bartz and Greg Roumeliotis WASHINGTON D.C./NEW YORK (Reuters) – As the global agricultural sector races to consolidate, Bayer AG's $66 billion all-cash deal to acquire Monsanto Co will test growing political and consumer unease in the United States and abroad over the future of food production. Bayer’s pesticide-focused agricultural business has few overlaps…

  • Bayer clinches Monsanto with improved $66 billion bid

    —

    by

    publisher
    in

    NEW YORK/FRANKFURT (Reuters) – German drug and crop chemical maker Bayer clinched a $66 billion takeover of U.S. seeds company Monsanto on Wednesday, ending months of wrangling with a third sweetened offer that marks the largest all-cash deal on record. The $128-a-share deal, up from Bayer's previous offer of $127.50 a share, has emerged as…

  • Chiesi nears cardiovascular assets deal with Medicine Co: sources

    —

    by

    admin
    in

    By Carl O’Donnell and Greg Roumeliotis (Reuters) – Italian specialty pharmaceutical company Chiesi Farmaceutici SpA is close to an agreement to acquire some of Medicines Co’s cardiovascular assets for several hundred millions of dollars, according to people familiar with the matter. The transaction would allow Chiesi to expand its global footprint, while freeing up capital…